Methsuximide (Epilepsy = All indications) updated on 04-22-2025

Table   Graphic     exposition period:

Congenital malformations
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
All congenital malformations (majors, minors, majors and minors, or unspecified)45.77 [2.84, 737.32]0%2 studies1392not evaluable ROB91.03 [5.13; .]
Major congenital malformations45.77 [2.84, 737.32]0%2 studies1392not evaluable ROB91.03 [5.13; .]